| Cancer-associated venous thromboembolic disease, version 2.2021, NCCN clinical practice guidelines in oncology MB Streiff, B Holmstrom, D Angelini, A Ashrani, A Elshoury, J Fanikos, ... Journal of the National Comprehensive Cancer Network 19 (10), 1181-1201, 2021 | 164 | 2021 |
| Failure of dabigatran and rivaroxaban to prevent thromboembolism in antiphospholipid syndrome: a case series of three patients JK Schaefer, RD McBane, DF Black, LN Williams, KG Moder, ... Thrombosis and haemostasis 112 (11), 947-950, 2014 | 113 | 2014 |
| Anticoagulation of cancer patients with non‐valvular atrial fibrillation receiving chemotherapy: guidance from the SSC of the ISTH A Delluc, TF Wang, ES Yap, C Ay, J Schaefer, M Carrier, S Noble Journal of thrombosis and haemostasis 17 (8), 1247-1252, 2019 | 76 | 2019 |
| How to choose appropriate direct oral anticoagulant for patient with nonvalvular atrial fibrillation JK Schaefer, RD McBane, WE Wysokinski Annals of hematology 95, 437-449, 2016 | 72 | 2016 |
| New biomarkers and imaging approaches for the diagnosis of deep venous thrombosis JK Schaefer, B Jacobs, TW Wakefield, SL Sood Current opinion in hematology 24 (3), 274-281, 2017 | 47 | 2017 |
| Adverse events associated with the addition of aspirin to direct oral anticoagulant therapy without a clear indication JK Schaefer, J Errickson, Y Li, X Kong, T Alexandris-Souphis, MA Ali, ... JAMA internal medicine 181 (6), 817-824, 2021 | 43 | 2021 |
| Association of adding aspirin to warfarin therapy without an apparent indication with bleeding and other adverse events JK Schaefer, Y Li, X Gu, NM Souphis, B Haymart, E Kline-Rogers, ... JAMA Internal Medicine 179 (4), 533-541, 2019 | 41 | 2019 |
| A provider's guide to primary myelofibrosis: pathophysiology, diagnosis, and management B Garmezy, JK Schaefer, J Mercer, M Talpaz Blood reviews 45, 100691, 2021 | 36 | 2021 |
| Cost‐effectiveness analysis of low‐dose direct oral anticoagulant (DOAC) for the prevention of cancer‐associated thrombosis in the United States A Li, JJ Carlson, NM Kuderer, JK Schaefer, S Li, DA Garcia, AA Khorana, ... Cancer 126 (8), 1736-1748, 2020 | 34 | 2020 |
| Anticoagulant medication adherence for cancer‐associated thrombosis: a comparison of LMWH to DOACs JK Schaefer, M Li, Z Wu, T Basu, MP Dorsch, GD Barnes, M Carrier, ... Journal of Thrombosis and Haemostasis 19 (1), 212-220, 2021 | 28 | 2021 |
| Use of GMI‐1271, an E‐selectin antagonist, in healthy subjects and in 2 patients with calf vein thrombosis S Devata, DE Angelini, S Blackburn, A Hawley, DD Myers, JK Schaefer, ... Research and Practice in Thrombosis and Haemostasis 4 (2), 193-204, 2020 | 18 | 2020 |
| How to choose an appropriate anticoagulant for cancer-associated thrombosis JK Schaefer, A Elshoury, VR Nachar, MB Streiff, MY Lim Journal of the National Comprehensive Cancer Network 19 (10), 1203-1210, 2021 | 14 | 2021 |
| Assessment of an intervention to reduce aspirin prescribing for patients receiving warfarin for anticoagulation JK Schaefer, J Errickson, X Gu, T Alexandris-Souphis, MA Ali, B Haymart, ... JAMA Network Open 5 (9), e2231973-e2231973, 2022 | 11 | 2022 |
| Update on guidelines for the prevention of cancer-associated thrombosis A Elshoury, JK Schaefer, MY Lim, DP Skalla, MB Streiff Journal of the National Comprehensive Cancer Network 20 (13), 2022 | 9 | 2022 |
| Sociodemographic factors in patients continuing warfarin vs those transitioning to direct oral anticoagulants JK Schaefer, SL Sood, B Haymart, X Gu, X Kong, E Kline-Rogers, ... Blood Advances 1 (26), 2536-2540, 2017 | 8 | 2017 |
| Identification of undocumented over-the-counter medications in an academic nephrology clinic AN Kokaly, JE Kurlander, K Pais, C Lee, JK Schaefer, M Heung, ... Journal of the American Pharmacists Association 60 (6), e236-e245, 2020 | 7 | 2020 |
| Monoclonal gammopathy of thrombotic/thrombocytopenic significance AJ Kanack, JK Schaefer, M Sridharan, NP Splinter, MC Kohlhagen, ... Blood 141 (14), 1772-1776, 2023 | 6 | 2023 |
| Retrospective cohort analysis of aspirin use and venous thromboembolism in patients with pancreatic cancer and an indwelling central venous catheter R King, J Schaefer, V Sahai, KA Griffith, SL Sood TH Open 6 (03), e221-e229, 2022 | 5 | 2022 |
| Primary myelofibrosis evolving to an aplastic appearing marrow JK Schaefer, SM Choi, GD Luker, TL Chenevert, BD Ross, M Talpaz Clinical Case Reports 6 (7), 1393, 2018 | 5 | 2018 |
| Prophylactic anticoagulation in patients with cancer: when and how? L Shevell, M Ochs, J Schaefer Current Oncology Reports 25 (3), 201-209, 2023 | 3 | 2023 |
